Search results
People also ask
What is clearmind's cmnd-100 clinical trial?
Who is clearmind medicine?
What is clearmind psychedelics?
Is clearmind a cure for alcoholism?
Clearmind develops novel psychedelic medicines to solve widespread—yet under-served—health problems. With a strong medical management and IP-protected treatments, we can better the lives of millions.
- Our Team
Our Team - Clearmind Medicine
- News Releases
News Releases - Clearmind Medicine
- Science and IP
Clearmind’s novel treatment candidates are backed by...
- Investors
Investors - Clearmind Medicine
- Our Team
Mar 13, 2024 · Clearmind Medicine is a biotech company developing novel psychedelic-derived therapeutics for alcohol use disorder. It has received approval to start a phase I/IIa trial of its oral capsule CMND-100, a non-hallucinogenic molecule that reduces alcohol cravings.
May 7, 2024 · Under the terms of the agreement, Clearmind receives exclusive rights to develop, manufacture, and commercialize novel compounds for treating PTSD and other mental health disorders.
Mar 13, 2024 · Clearmind Medicine, a biotech company developing novel psychedelic-derived therapeutics, has received clearance from the Israeli Ministry of Health to start its phase I/IIa clinical trial for alcohol use disorder. The trial will evaluate the safety, pharmacokinetics and efficacy of CMND-100, a non-hallucinogenic oral capsule containing MEAI, in healthy volunteers and AUD patients.
Nov 9, 2023 · Clearmind is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health...
Jan 10, 2024 · Clearmind is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health...
May 10, 2024 · Clearmind Medicine is a biotech company developing novel psychedelic-derived therapeutics, including a MEAI-based alcohol substitute beverage. The Company has completed most of the pre-clinical studies and has patents in the U.S., India and Europe for this product.